At meeting held on 08 November 2021
The Board of ANG Lifesciences India at its meeting held on 08 November 2021 has decided to invest in the Equity Shares and Redeemable Cumulative Preference Shares of Baddi Agro. Consequent to the acquisition of 51% Equity stake by the Company, Baddi Agro will become the Subsidiary Company of ANG Lifesciences India.Baddi Agro has manufacturing unit situated at Baddi Himachal Pradesh (formerly known as Surya Pharmaceutical) which is laced with latest machinery and located proximate to Mentha Leaf cultivation area.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app